North America Neurostimulation Devices Market

North America Neurostimulation Devices Market By Devices (Spinal Cord Stimulators, Deep Brain Stimulators, Sacral Nerve Stimulators, Vagus Nerve Stimulators and Other Devices) By Applications (Pain Management, Hearing Loss, Urinary Incontinence, Parkinson's Disease, Epilepsy and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026

Report Id: KBV-4252 Publication Date: June-2020 Number of Pages: 86
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Neurostimulation Devices Market, by Devices
1.4.2 North America Neurostimulation Devices Market, by Applications
1.4.3 North America Neurostimulation Devices Market, by Country
1.5 Methodology for the research

Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints

Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements : 2016, Oct – 2020, May) Leading Players

Chapter 4. North America Neurostimulation Devices Market by Devices
4.1 North America Spinal Cord Stimulators Market by Country
4.2 North America Deep Brain Stimulators Market by Country
4.3 North America Sacral Nerve Stimulators Market by Country
4.4 North America Vagus Nerve Stimulators Market by Country
4.5 North America Other Devices Market by Country

Chapter 5. North America Neurostimulation Devices Market by Applications
5.1 North America Pain Management Market by Country
5.2 North America Hearing Loss Market by Country
5.3 North America Urinary Incontinence Market by Country
5.4 North America Parkinson's Disease Market by Country
5.5 North America Epilepsy Market by Country
5.6 North America Other Applications Market by Country

Chapter 6. North America Neurostimulation Devices Market by Country
6.1 US Neurostimulation Devices Market
6.1.1 US Neurostimulation Devices Market by Devices
6.1.2 US Neurostimulation Devices Market by Applications
6.2 Canada Neurostimulation Devices Market
6.2.1 Canada Neurostimulation Devices Market by Devices
6.2.2 Canada Neurostimulation Devices Market by Applications
6.3 Mexico Neurostimulation Devices Market
6.3.1 Mexico Neurostimulation Devices Market by Devices
6.3.2 Mexico Neurostimulation Devices Market by Applications
6.4 Rest of North America Neurostimulation Devices Market
6.4.1 Rest of North America Neurostimulation Devices Market by Devices
6.4.2 Rest of North America Neurostimulation Devices Market by Applications

Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 Boston Scientific Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.5.2 Product Launches and Product Expansions:
7.3 Nevro Corporation
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Medtronic PLC
7.4.1 Company overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Partnerships, Collaborations, and Agreements:
7.4.5.2 Acquisition and Mergers:
7.4.5.3 Product Launches and Product Expansions:
7.4.5.4 Approvals:
7.5 NeuroSigma, Inc.
7.5.1 Company Overview
7.5.2 Recent strategies and developments:
7.5.2.1 Partnerships, Collaborations, and Agreements:
7.6 Integer Holdings Corporation
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 LivaNova PLC
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.7.5 Recent strategies and developments:
7.7.5.1 Approvals:
7.7.5.2 Acquisition and Mergers:
7.8 NeuroPace, Inc.
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Approvals:
7.8.2.2 Product Launches and Product Expansions:
7.9 Neuronetics, Inc.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.9.5.2 Approvals:
7.1 Synapse BioMedical, Inc.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Approvals:
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo